IFN-alpha 4 Antibody (1020125) [Janelia Fluor® 646]
Novus Biologicals, part of Bio-Techne | Catalog # FAB10259J
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Immunohistochemistry
Label
Janelia Fluor 646
Antibody Source
Monoclonal Rat IgG2A Clone # 1020125
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human embryonic kidney cell HEK293-derived mouse IFN-alpha 4
Leu23-Glu186
Accession # P07351
Leu23-Glu186
Accession # P07351
Specificity
Detects mouse IFN-alpha 4 in direct ELISAs. In direct ELISAS, no cross-reactivity with recombinant mouse IFNA-1, -2, -6, -7, -9, -11, -12, -13, -15 or -16 is observed.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Applications for IFN-alpha 4 Antibody (1020125) [Janelia Fluor® 646]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IFN-alpha 4
Long Name
Interferon alpha 4
Alternate Names
IFNA4, IFNalpha 4
Additional IFN-alpha 4 Products
Product Documents for IFN-alpha 4 Antibody (1020125) [Janelia Fluor® 646]
Product Specific Notices for IFN-alpha 4 Antibody (1020125) [Janelia Fluor® 646]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...